ArticleClinical genitourinary cancer2022

Validation of Prognostic Scores in Patients With Metastatic Urothelial Cancer Enrolling in Phase I Targeted Therapy or Next Generation Immunotherapy Trials.

Omar Alhalabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.